First‐in‐human positron emission tomography study of intranasal insulin in aging and MCI

Documenti analoghi

• Omics‐derived biological modules reflect tau positron emission tomography in Alzheimer's disease
  di: Si‐Chun Gu, et al.
  Pubblicazione: (2025)
• The HOPE4MCI study: A randomized double‐blind assessment of AGB101 for the treatment of MCI due to AD
  di: Richard Mohs, et al.
  Pubblicazione: (2024)
• A phase 2A/B randomized trial of metabolic modulators intranasal insulin and empagliflozin for MCI and early AD
  di: Jennifer M. Erichsen, et al.
  Pubblicazione: (2025)
• Distribution of insulin in primate brain following nose‐to‐brain transport
  di: Kylie Smith, et al.
  Pubblicazione: (2024)
• The HOPE4MCI study: AGB101 treatment slows progression of entorhinal cortex atrophy in APOE ε4 non‐carriers with mild cognitive impairment due to Alzheimer's disease
  di: Arnold Bakker, et al.
  Pubblicazione: (2024)